000			02101 a2200517 4500
005			20250514233717.0
264		0	_c20050914
008			200509s 0 0 eng d
022			_a0008-5472
024	7		_a10.1158/0008-5472.CAN-05-0933 _2doi
040			_aNLM _beng _cNLM
100	1		_aShimamura, Takeshi
245	0	0	_aEpidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins. _h[electronic resource]
260			_bCancer research _cJul 2005
300			_a6401-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntibiotics, Antineoplastic _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBenzoquinones
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCyclin D1 _xmetabolism
650	0	4	_aCysteine Proteinase Inhibitors _xpharmacology
650	0	4	_aErbB Receptors _xgenetics
650	0	4	_aGene Deletion
650	0	4	_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors
650	0	4	_aHumans
650	0	4	_aLactams, Macrocyclic
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMice
650	0	4	_aMitogen-Activated Protein Kinase 1 _xantagonists & inhibitors
650	0	4	_aMitogen-Activated Protein Kinase 3 _xantagonists & inhibitors
650	0	4	_aNIH 3T3 Cells
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aProtein Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aProtein Structure, Tertiary
650	0	4	_aProto-Oncogene Proteins _xantagonists & inhibitors
650	0	4	_aProto-Oncogene Proteins c-akt
650	0	4	_aQuinones _xpharmacology
700	1		_aLowell, April M
700	1		_aEngelman, Jeffrey A
700	1		_aShapiro, Geoffrey I
773	0		_tCancer research _gvol. 65 _gno. 14 _gp. 6401-8
856	4	0	_uhttps://doi.org/10.1158/0008-5472.CAN-05-0933 _zAvailable from publisher's website
999			_c15679778 _d15679778